Skip to content

Charles H. Moore, MD

NPI 1275533044ActiveIndividual· Internal Medicine, Cardiovascular Disease· Kingwood, TX

Internal Medicine, Cardiovascular Disease (MD) in Kingwood, Texas, licensed in TX, with an NPI issued in July 2005. Part D covered 50 prescriptions written in 2024, 92% of them generic. Novo Nordisk Inc reported $17.64 in payments in 2025, mostly food and beverage.

Overview

NPI1275533044
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 22, 2005
Last updated in NPPESFeb 3, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000XF8954TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)50 · 110 30-day fills
Patients28
Total drug cost$3,445
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$17.64 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$17.641

What the 2025 payments were for

  • Food and Beverage$17.64 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Kingwood

All Internal Medicine, Cardiovascular Disease providers in Texas →